Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2400

1.

Women's views on screening for Type 2 diabetes after gestational diabetes: a systematic review, qualitative synthesis and recommendations for increasing uptake.

Dennison RA, Fox RA, Ward RJ, Griffin SJ, Usher-Smith JA.

Diabet Med. 2019 Jul 18. doi: 10.1111/dme.14081. [Epub ahead of print]

PMID:
31317569
2.

Demyelinating lesions and progressive MS: Location, location, location.

Yeh EA, Fox RJ.

Neurology. 2019 Jul 9. pii: 10.1212/WNL.0000000000007933. doi: 10.1212/WNL.0000000000007933. [Epub ahead of print] No abstract available.

PMID:
31289147
3.

Perceived Discrimination and Cardiometabolic Risk Among US Hispanics/Latinos in the HCHS/SOL Sociocultural Ancillary Study.

Fox RS, Carnethon MR, Gallo LC, Wiley JF, Isasi CR, Daviglus ML, Cai J, Davis SM, Giachello AL, Gonzalez P, McCurley JL, Schneiderman N, Penedo FJ.

Int J Behav Med. 2019 Jun 24. doi: 10.1007/s12529-019-09782-7. [Epub ahead of print]

PMID:
31236872
4.

Too Much Compromise in Today's CRISPR Pipelines.

Fox R.

CRISPR J. 2019 Jun;2:143-145. doi: 10.1089/crispr.2019.0015.

PMID:
31225751
5.

The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials.

Chataway J, Weir CJ, Fox RJ.

Mult Scler. 2019 Jun 20:1352458519856985. doi: 10.1177/1352458519856985. [Epub ahead of print] No abstract available.

PMID:
31218918
6.

Sofosbuvir/Velpatasvir for 12 Weeks in Hepatitis C Virus-Infected Patients with End-Stage Renal Disease Undergoing Dialysis.

Borgia SM, Dearden J, Yoshida EM, Shafran SD, Brown A, Ben-Ari Z, Cramp ME, Cooper C, Foxton M, Rodriguez CF, Esteban R, Hyland R, Lu S, Kirby B, Meng A, Markova S, Dvory-Sobol H, Osinusi AO, Bruck R, Ampuero J, Ryder SD, Agarwal K, Fox R, Shaw D, Haider S, Willems B, Lurie Y, Calleja JL, Gane EJ.

J Hepatol. 2019 Jun 10. pii: S0168-8278(19)30343-5. doi: 10.1016/j.jhep.2019.05.028. [Epub ahead of print]

7.

Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment.

Berhane S, Fox R, García-Fiñana M, Cucchetti A, Johnson P.

Br J Cancer. 2019 Jul;121(2):117-124. doi: 10.1038/s41416-019-0488-4. Epub 2019 Jun 11.

PMID:
31182766
8.

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.

Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.

BMC Neurol. 2019 Jun 8;19(1):116. doi: 10.1186/s12883-019-1337-z.

9.

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis.

Marrie RA, Dufault B, Tyry T, Cutter GR, Fox RJ, Salter A.

Mult Scler. 2019 Jun 4:1352458519852722. doi: 10.1177/1352458519852722. [Epub ahead of print]

PMID:
31161917
10.

Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy.

Fox RS, Ancoli-Israel S, Roesch SC, Merz EL, Mills SD, Wells KJ, Sadler GR, Malcarne VL.

Support Care Cancer. 2019 Jun 3. doi: 10.1007/s00520-019-04834-w. [Epub ahead of print]

PMID:
31161437
11.

A critical analysis of Powell's results on the interdivision time distribution.

Quedeville V, Morchain J, Villedieu P, Fox RO.

Sci Rep. 2019 Jun 3;9(1):8165. doi: 10.1038/s41598-019-44606-4.

12.

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Coffin PO, Santos GM, Behar E, Hern J, Walker J, Matheson T, Kinnard EN, Silvis J, Vittinghoff E, Fox R, Page K.

PLoS One. 2019 Jun 3;14(6):e0217471. doi: 10.1371/journal.pone.0217471. eCollection 2019.

13.

Discovery of vascular Rho kinase (ROCK) inhibitory peptides.

Abbasgholizadeh R, Zhang H, Craft JW Jr, Bryan RM Jr, Bark SJ, Briggs JM, Fox RO, Agarkov A, Zimmer WE, Gilbertson SR, Schwartz RJ.

Exp Biol Med (Maywood). 2019 May 27:1535370219849581. doi: 10.1177/1535370219849581. [Epub ahead of print]

PMID:
31132884
14.

Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ.

Mol Genet Genomic Med. 2019 Jul;7(7):e00736. doi: 10.1002/mgg3.736. Epub 2019 May 13.

15.

Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Mult Scler. 2019 May 13:1352458519845836. doi: 10.1177/1352458519845836. [Epub ahead of print]

PMID:
31079537
16.

The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments.

Salter A, Fox RJ, Tyry T, Cutter G, Marrie RA.

Mult Scler Relat Disord. 2019 Jun;31:165-172. doi: 10.1016/j.msard.2019.04.014. Epub 2019 Apr 13.

PMID:
31063935
17.

Integrating PROMIS® computerized adaptive tests into a web-based intervention for prostate cancer.

Fox RS, Moreno PI, Yanez B, Estabrook R, Thomas J, Bouchard LC, McGinty HL, Mohr DC, Begale MJ, Flury SC, Perry KT, Kundu SD, Penedo FJ.

Health Psychol. 2019 May;38(5):403-409. doi: 10.1037/hea0000672.

PMID:
31045423
18.

Treatment of Sjögren's syndrome: current therapy and future directions.

Fox RI, Fox CM, Gottenberg JE, Dörner T.

Rheumatology (Oxford). 2019 Apr 26. pii: kez142. doi: 10.1093/rheumatology/kez142. [Epub ahead of print]

PMID:
31034046
19.

New Approaches in Hypertension Management: a Review of Current and Developing Technologies and Their Potential Impact on Hypertension Care.

Kitt J, Fox R, Tucker KL, McManus RJ.

Curr Hypertens Rep. 2019 Apr 25;21(6):44. doi: 10.1007/s11906-019-0949-4. Review.

20.

Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression.

Bowlt Blacklock KL, Birand Z, Selmic LE, Nelissen P, Murphy S, Blackwood L, Bass J, McKay J, Fox R, Beaver S, Starkey M.

Sci Rep. 2019 Apr 24;9(1):6511. doi: 10.1038/s41598-019-42839-x.

21.

Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer.

Evans DG, Thomas S, Caunt J, Burch A, Brentnall AR, Roberts L, Howell A, Wilson M, Fox R, Hillier S, Sibbering DM, Moss S, Wallis MG, Eccles DM; FH02 study group, Duffy S.

EClinicalMedicine. 2019 Jan;7:39-46. doi: 10.1016/j.eclinm.2019.01.005.

22.

Sexual selection, phenotypic plasticity and female reproductive output.

Fox RJ, Fromhage L, Jennions MD.

Philos Trans R Soc Lond B Biol Sci. 2019 Mar 18;374(1768):20180184. doi: 10.1098/rstb.2018.0184.

PMID:
30966965
23.

Beyond buying time: the role of plasticity in phenotypic adaptation to rapid environmental change.

Fox RJ, Donelson JM, Schunter C, Ravasi T, Gaitán-Espitia JD.

Philos Trans R Soc Lond B Biol Sci. 2019 Mar 18;374(1768):20180174. doi: 10.1098/rstb.2018.0174.

24.

A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma.

Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T.

Cell. 2019 Apr 18;177(3):572-586.e22. doi: 10.1016/j.cell.2019.03.010. Epub 2019 Apr 4.

PMID:
30955884
25.

Psychosocial and neighborhood correlates of health-related quality of life: A multi-level study among Hispanic adults.

Mills SD, Fox RS, Bohan S, Roesch SC, Sadler GR, Malcarne VL.

Cultur Divers Ethnic Minor Psychol. 2019 Apr 1. doi: 10.1037/cdp0000274. [Epub ahead of print]

PMID:
30932506
26.

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group.

Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Erratum in: Lancet Oncol. 2019 Apr 2;:.

PMID:
30922733
27.

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.

Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ.

Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27.

28.

Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.

Gulliford MC, Juszczyk D, Prevost AT, Soames J, McDermott L, Sultana K, Wright M, Fox R, Hay AD, Little P, Moore M, Yardley L, Ashworth M, Charlton J.

Health Technol Assess. 2019 Mar;23(11):1-70. doi: 10.3310/hta23110.

29.

Author response: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance.

Muraro PA, Scolding NJ, Fox RJ.

Neurology. 2019 Mar 19;92(12):586. doi: 10.1212/WNL.0000000000007128. No abstract available.

PMID:
30886076
30.

Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B.

Fox RK, Taddei TH, Kaplan DE.

JAMA Intern Med. 2019 Mar 18. doi: 10.1001/jamainternmed.2018.8314. [Epub ahead of print] No abstract available.

PMID:
30882884
31.

A survey of risk tolerance to multiple sclerosis therapies.

Fox RJ, Cosenza C, Cripps L, Ford P, Mercer M, Natarajan S, Salter A, Tyry T, Cofield SS.

Neurology. 2019 Apr 2;92(14):e1634-e1642. doi: 10.1212/WNL.0000000000007245. Epub 2019 Mar 13.

32.

Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected.

Dosani T, Covut F, Pinto R, Kim BG, Ali N, Beck R, Maitta R, Downes K, Fox R, Reese J, de Lima M, Malek E.

Leuk Lymphoma. 2019 Mar 7:1-8. doi: 10.1080/10428194.2019.1573367. [Epub ahead of print]

PMID:
30845862
33.

Assessment of Trauma Symptoms in Toddlers and Preschoolers Living in Poverty.

Bollens SH, Fox RA.

Child Maltreat. 2019 Aug;24(3):275-285. doi: 10.1177/1077559519830790. Epub 2019 Mar 6.

PMID:
30841724
34.

Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial.

Gulliford MC, Prevost AT, Charlton J, Juszczyk D, Soames J, McDermott L, Sultana K, Wright M, Fox R, Hay AD, Little P, Moore MV, Yardley L, Ashworth M.

BMJ. 2019 Feb 12;364:l236. doi: 10.1136/bmj.l236.

35.

Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Mowry EM, Marrie RA.

Mult Scler Relat Disord. 2019 Apr;29:86-93. doi: 10.1016/j.msard.2019.01.031. Epub 2019 Jan 24.

PMID:
30690340
36.

Making Space for Community Critical Methodology: Stories from the Australian Context.

Fox R, Nic Giolla Easpaig B, Watson L.

Am J Community Psychol. 2019 Mar;63(1-2):227-238. doi: 10.1002/ajcp.12302. Epub 2019 Jan 25.

PMID:
30681734
37.

Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.

Kaplan DE, Serper MA, Mehta R, Fox R, John B, Aytaman A, Baytarian M, Hunt K, Albrecht J, Njei B, Taddei TH; VOCAL Study Group.

Gastroenterology. 2019 May;156(6):1693-1706.e12. doi: 10.1053/j.gastro.2019.01.026. Epub 2019 Jan 18.

38.

Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND): protocol for a randomised feasibility trial.

Morris E, Aveyard P, Dyson P, Noreik M, Bailey C, Fox R, Hoffman K, Tan GD, Jebb SA.

BMJ Open. 2019 Jan 17;9(1):e026460. doi: 10.1136/bmjopen-2018-026460.

39.

Effects of regional dialect on oral-nasal balance and nasality perception.

Velik K, Bae Y, Fox RA.

Clin Linguist Phon. 2019;33(7):587-600. doi: 10.1080/02699206.2019.1566402. Epub 2019 Jan 15.

PMID:
30646769
40.

Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Neurol Clin Pract. 2018 Dec;8(6):472-481. doi: 10.1212/CPJ.0000000000000523.

PMID:
30588376
41.

Identification of molecular genetic contributants to canine cutaneous mast cell tumour metastasis by global gene expression analysis.

Bowlt Blacklock K, Birand Z, Biasoli D, Fineberg E, Murphy S, Flack D, Bass J, Di Palma S, Blackwood L, McKay J, Whitbread T, Fox R, Eve T, Beaver S, Starkey M.

PLoS One. 2018 Dec 19;13(12):e0208026. doi: 10.1371/journal.pone.0208026. eCollection 2018.

42.

Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL.

Clegg LE, Heerspink HJL, Penland RC, Tang W, Boulton DW, Bachina S, Fox RD, Fenici P, Thuresson M, Mentz RJ, Hernandez AF, Holman RR.

Diabetes Care. 2019 Feb;42(2):318-326. doi: 10.2337/dc18-1871. Epub 2018 Dec 6.

PMID:
30523029
43.

Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion.

Tawara K, Scott H, Emathinger J, Ide A, Fox R, Greiner D, LaJoie D, Hedeen D, Nandakumar M, Oler AJ, Holzer R, Jorcyk C.

Transl Oncol. 2019 Feb;12(2):245-255. doi: 10.1016/j.tranon.2018.10.004. Epub 2018 Nov 12.

44.

C-H Arylation in the Formation of a Complex Pyrrolopyridine, the Commercial Synthesis of the Potent JAK2 Inhibitor, BMS-911543.

Fox RJ, Cuniere NL, Bakrania L, Wei C, Strotman NA, Hay M, Fanfair D, Regens C, Beutner GL, Lawler M, Lobben P, Soumeillant MC, Cohen B, Zhu K, Skliar D, Rosner T, Markwalter CE, Hsiao Y, Tran K, Eastgate MD.

J Org Chem. 2019 Apr 19;84(8):4661-4669. doi: 10.1021/acs.joc.8b02383. Epub 2018 Nov 12.

PMID:
30388009
45.

Under expression of the Sonic Hedgehog receptor, Patched1 (PTCH1), is associated with an increased risk of local recurrence in squamous cell carcinoma of the vulva arising on a background of Lichen Sclerosus.

Yap J, Fox R, Narsia N, Pinheiro-Maia S, Pounds R, Woodman C, Luesley D, Ganesan R, Kehoe S, Dawson C.

PLoS One. 2018 Oct 31;13(10):e0206553. doi: 10.1371/journal.pone.0206553. eCollection 2018.

46.

Joint longitudinal and time-to-event models for multilevel hierarchical data.

Brilleman SL, Crowther MJ, Moreno-Betancur M, Buros Novik J, Dunyak J, Al-Huniti N, Fox R, Hammerbacher J, Wolfe R.

Stat Methods Med Res. 2018 Oct 31:962280218808821. doi: 10.1177/0962280218808821. [Epub ahead of print]

PMID:
30378472
47.

The 5-HT2A Receptor (5-HT2AR) Regulates Impulsive Action and Cocaine Cue Reactivity in Male Sprague-Dawley Rats.

Sholler DJ, Stutz SJ, Fox RG, Boone EL, Wang Q, Rice KC, Moeller FG, Anastasio NC, Cunningham KA.

J Pharmacol Exp Ther. 2019 Jan;368(1):41-49. doi: 10.1124/jpet.118.251199. Epub 2018 Oct 29.

48.

A new NBIA patient from Turkey with homozygous C19ORF12 mutation.

Kasapkara ÇS, Tümer L, Gregory A, Ezgü F, İnci A, Derinkuyu BE, Fox R, Rogers C, Hayflick S.

Acta Neurol Belg. 2018 Oct 8. doi: 10.1007/s13760-018-1026-5. [Epub ahead of print] No abstract available.

PMID:
30298423
49.

Use of eHealth and mHealth technology by persons with multiple sclerosis.

Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A.

Mult Scler Relat Disord. 2019 Jan;27:13-19. doi: 10.1016/j.msard.2018.09.036. Epub 2018 Oct 2.

PMID:
30296732
50.

Quality not quantity: loneliness subtypes, psychological trauma, and mental health in the US adult population.

Hyland P, Shevlin M, Cloitre M, Karatzias T, Vallières F, McGinty G, Fox R, Power JM.

Soc Psychiatry Psychiatr Epidemiol. 2018 Oct 6. doi: 10.1007/s00127-018-1597-8. [Epub ahead of print]

PMID:
30293176

Supplemental Content

Support Center